5MSG image
Deposition Date 2017-01-04
Release Date 2017-02-08
Last Version Date 2024-03-06
Entry Detail
PDB ID:
5MSG
Keywords:
Title:
Influenza B polymerase bound to vRNA promoter and capped RNA primer
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
3.80 Å
R-Value Free:
0.26
R-Value Work:
0.23
R-Value Observed:
0.23
Space Group:
P 32 2 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Polymerase acidic protein
Gene (Uniprot):PA
Chain IDs:A
Chain Length:751
Number of Molecules:1
Biological Source:Influenza B virus
Polymer Type:polypeptide(L)
Molecule:RNA-directed RNA polymerase catalytic subunit
Gene (Uniprot):PB1
Chain IDs:B
Chain Length:772
Number of Molecules:1
Biological Source:Influenza B virus
Polymer Type:polypeptide(L)
Molecule:Polymerase basic protein 2
Gene (Uniprot):PB2
Chain IDs:C
Chain Length:798
Number of Molecules:1
Biological Source:Influenza B virus
Polymer Type:polyribonucleotide
Molecule:RNA (5'-D(*(GDM))-R(P*AP*AP*UP*C)-3')
Chain IDs:D (auth: M)
Chain Length:14
Number of Molecules:1
Biological Source:synthetic construct
Polymer Type:polyribonucleotide
Molecule:RNA (5'-R(*UP*AP*UP*AP*CP*CP*UP*CP*UP*GP*CP*UP*UP*CP*UP*GP*CP*U)-3')
Chain IDs:E (auth: R)
Chain Length:18
Number of Molecules:1
Biological Source:Influenza B virus
Polymer Type:polyribonucleotide
Molecule:RNA (5'-R(P*AP*GP*UP*AP*GP*UP*AP*AP*CP*AP*AP*GP*AP*G)-3')
Chain IDs:F (auth: V)
Chain Length:14
Number of Molecules:1
Biological Source:Influenza B virus
Ligand Molecules
Primary Citation
An in vitro fluorescence based study of initiation of RNA synthesis by influenza B polymerase.
Nucleic Acids Res. 45 3353 3368 (2017)
PMID: 28126917 DOI: 10.1093/nar/gkx043

Abstact

Influenza polymerase replicates, via a complementary RNA intermediate (cRNA), and transcribes the eight viral RNA (vRNA) genome segments. To initiate RNA synthesis it is bound to the conserved 5΄ and 3΄ extremities of the vRNA or cRNA (the 'promoter'). 5΄-3΄ base-pairing in the distal promoter region is essential to position the template RNA at the polymerase active site, as shown by a new crystal structure with the 3΄ end threading through the template entry tunnel. We develop fluorescence polarization assays to quantify initiation of cap-primed (transcription) or unprimed (replication) RNA synthesis by recombinant influenza B polymerase bound to the vRNA or cRNA promoter. The rate-limiting step is formation of a primed initiation complex with minimally ApG required to stabilize the 3΄ end of the template within the active-site. Polymerase bound to the vRNA promoter initiates RNA synthesis terminally, while the cRNA promoter directs internal initiation at a significantly lower rate. Progression to elongation requires breaking the promoter 5΄-3΄ base-pairing region and favourable compensation by the emerging template-product base-pairs. The RNA synthesis assay is adaptable to high-throughput screening for polymerase inhibitors. In a pilot study, we find that initiation at the cRNA promoter is unusually susceptible to inhibition by 2΄F-2΄dNTPs.

Legend

Protein

Chemical

Disease

Primary Citation of related structures